Comparison of DPP-4 Inhibitors
Nam Hoon Kim, Sin Gon Kim
openaire +1 more source
GPU-Accelerated Virtual Screening and Molecular Dynamics Simulations for Identification of Novel DPP‑4 Inhibitors. [PDF]
Vasquez-Martínez N +5 more
europepmc +1 more source
Concomitant Use of DPP-4 Inhibitors May Prevent the Development of Oxaliplatin-Induced Peripheral Neuropathy: A Retrospective Cohort Study. [PDF]
Koura Y +9 more
europepmc +1 more source
Risk of Dementia in Patients With Type 2 Diabetes Using SGLT2 Inhibitors Versus DPP-4 Inhibitors: A Systematic Review and Meta-Analysis. [PDF]
Kumari K +10 more
europepmc +1 more source
Repurposing DPP-4 inhibitors as anticancer agents in KRAS-mutated pancreatic ductal adenocarcinoma. [PDF]
Ramalingam PS +12 more
europepmc +1 more source
Risk of acute pancreatitis with DPP-4 inhibitors versus SGLT2 inhibitors in medication-naïve individuals with diabetes: A target trial emulation. [PDF]
Tatewaki T +3 more
europepmc +1 more source
Analgesic and anti-inflammatory effectiveness of sitagliptin and vildagliptin in mice [PDF]
Cayasso, Mayella +6 more
core +1 more source
DPP-4 inhibitors for preventing post-stroke cognitive impairment in diabetic patients with acute ischemic stroke: a retrospective cohort study. [PDF]
Fu H, Liu J, Wu J, Zou F.
europepmc +1 more source
Can DPP-4 Inhibitors Improve Glycemic Control and Preserve Beta-Cell Function in Type 1 Diabetes Mellitus? A Systematic Review. [PDF]
Villa Chagas H +5 more
europepmc +1 more source

